CATHERINE O'CONNOR: Open Payments
NPI 1942526785 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 28 payments from 8 companies in 2025. Trend: 2023 $428 · 2024 $353 · 2025 $523
Food & beverage: $523
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $248 |
| Lilly USA, LLC | 4 | $71 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Exact Sciences Corporation | 2 | $41 |
| Astellas Pharma US Inc | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: VRAYLAR, QULIPTA, AIRSUPRA, MOUNJARO, The Cologuard Plus Collection Kit, JARDIANCE, Veozah, FANAPT.
Industry payments across TX — which companies pay providers there.
